As of Sep 28
| +0.009 / +6.92%|
The 1 analysts offering 12-month price forecasts for Inspyr Therapeutics Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +1,338.85% increase from the last price of 0.14.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.